Related Experiment Videos
Surveillance for antimicrobial resistance in enterococci
S L Taylor1, S Pottumarthy, C G Wong
1Auckland Hospital.
The New Zealand Medical Journal
|July 11, 1997
Summary
Antimicrobial resistance patterns in Auckland reveal that vancomycin resistance is rare in clinical enterococcal isolates. High-level gentamicin and streptomycin resistance were observed in 15% and 12% of isolates, respectively.
Area of Science:
- Clinical microbiology
- Infectious diseases
- Antimicrobial resistance
Background:
- Antimicrobial-resistant enterococci are significant nosocomial pathogens.
- Periodic local resistance pattern surveys are recommended for hospitals.
Purpose of the Study:
- To characterize antimicrobial resistance profiles of Enterococcus species in Auckland.
- To establish a local susceptibility baseline for enterococcal isolates.
Main Methods:
- Enterococcal isolates from four distinct patient groups were analyzed.
- Testing included beta-lactamase production, susceptibility to amoxycillin, teicoplanin, vancomycin, and high-level gentamicin/streptomycin resistance.
Main Results:
- Of 433 isolates, 74% were E. faecalis, 12% E. faecium. No beta-lactamase production was detected.
- All E. faecalis were amoxycillin-susceptible; two E. faecium and one other species showed resistance.
- Teicoplanin susceptibility was universal. Vancomycin resistance was rare, primarily intermediate in E. gallinarum/casseliflavus. High-level gentamicin and streptomycin resistance occurred in 15% and 12% of isolates, respectively.
Conclusions:
- Vancomycin resistance is uncommon and mainly associated with E. gallinarum/casseliflavus.
- The study established local enterococcal susceptibility patterns.
- This data facilitates comparison with other regions and monitors emerging resistance trends.